Evidence map›Paper›PMID 41691278›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026

CT-based multiple instance and ensemble learning for lymph node metastasis prediction in esophageal squamous cell carcinoma: a multicentre, retrospective study.

Kai Qin, Jianchao Lu, Na Li, Jie Zhu, Lin Peng, Jiayu Xiang, Yi Jin, Pei Yang, Junqiang Chen, Qifeng Wang

Abstract readMulticenter Study
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kai Qin *Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan Province, 610041, China.
Jianchao Lu *Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan Province, 610041, China.
Na LiCancer Central, Suining Central Hospital, Suining, Sichuan Province, China.
Jie ZhuDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan Province, 610041, China.
Lin PengDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China.
Jiayu XiangGraduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China.
Yi JinKey Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital, The Affiliate Hospital of Xiangya Medical School, Central South University, No.582, Xianjiahu Road, Changsha, Hunan Province, 410006, China.
Pei YangKey Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital, The Affiliate Hospital of Xiangya Medical School, Central South University, No.582, Xianjiahu Road, Changsha, Hunan Province, 410006, China. Yangpei@hnca.org.cn.
Junqiang ChenDepartment of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420, Fuma Road, Fuzhou, Fujian Province, 350014, China. junqiangc@163.com.
Qifeng WangDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan Province, 610041, China. littlecancer@163.com.

Funding

Science and Technology Department of Sichuan Province No.2023YFQ0055Science and Technology Department of Sichuan Province No.2023YFS0488
6 · The paper itself

Abstract

backgroundAccurately predicting lymph node metastasis (LNM) in esophageal squamous cell carcinoma (ESCC) is crucial for planning patient treatments. However, this task remains challenging, complicating treatment decision-making; this is particularly concerning for patients classified as pN0 owing to insufficient lymph node dissection (< 15 lymph nodes), as the effectiveness of postoperative adjuvant therapy (POAT) for these patients remains controversial. Therefore, we aimed to develop a CT-based predictive model to improve LNM detection in ESCC patients and identify pN0 patients who can benefit from POAT.

methodsWe retrospectively enrolled 974 ESCC patients who underwent radical esophagectomy with adequate lymph node dissection (≥ 15 lymph nodes), dividing them into training (432 patients), internal validation (185 patients), and external validation cohorts (357 patients). To predict LNM, we developed a Stacking model using multiple instance and ensemble learning, leveraging the visible lymph nodes, primary tumor features, and clinical characteristics of each patient. Additionally, we separately enrolled 386 pN0 patients who underwent insufficient lymph node dissection and classified them into low-risk and high-risk groups on the basis of the optimal cut-off value from the Stacking model. Kaplan‒Meier and Cox models were used to assess the impact of POAT on patient survival.

resultsThe Stacking model achieved area under the curve (AUC) values of 0.883, 0.834, and 0.819 in the training, internal validation, and external validation cohorts, respectively, outperforming traditional models based separately on tumor features, clinical characteristics, or the features of the largest lymph node. pN0 patients identified by the Stacking model as high risk had worse overall survival than low-risk patients did. POAT provided survival benefits for the high-risk patients but had no significant effect on the survival of low-risk patients.

conclusionOur Stacking model achieved excellent LNM prediction in ESCC patients and holds promise for guiding personalized treatment strategies, particularly for pN0 patients with insufficient lymph node dissection.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaLymphatic MetastasisTomography, X-Ray ComputedAgedEnsemble LearningEsophagectomyFemaleHumansLymph Node ExcisionLymph NodesMaleMiddle AgedRetrospective StudiesDeep learningEsophageal cancerLymph node metastasisRadiomics

Identifiers

PMID41691278
PMCPMC13011690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.